These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33123482)

  • 1. Prophylactic Extended-Field Irradiation in Patients With Cervical Cancer: A Literature Review.
    Wang W; Zhou Y; Wang D; Hu K; Zhang F
    Front Oncol; 2020; 10():579410. PubMed ID: 33123482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic extended-field irradiation for locally advanced cervical cancer.
    Li H; Wang S; Liu Y; Wang T; Jin S; Liu Z
    Gynecol Oncol; 2022 Sep; 166(3):606-613. PubMed ID: 35868881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
    Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
    Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
    Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
    Lee J; Lin JB; Chang CL; Jan YT; Sun FJ; Wu MH; Chen YJ
    Gynecol Oncol; 2017 Jul; 146(1):20-26. PubMed ID: 28457584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
    Lee J; Lin JB; Chang CL; Sun FJ; Wu MH; Jan YT; Chen YJ
    Gynecol Oncol; 2018 Feb; 148(2):291-298. PubMed ID: 29269219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Prophylactic Irradiation to Para-aortic Lymph Nodes in Locally Advanced Cervical Cancer Necessary?
    Park SG; Kim JH; Oh YK; Byun SJ; Kim MY; Kwon SH; Kim OB
    Cancer Res Treat; 2014 Oct; 46(4):374-82. PubMed ID: 25043821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer.
    Zhang G; Wang C; Ma C; Miao L; He F; Fu C
    Technol Cancer Res Treat; 2022; 21():15330338221141541. PubMed ID: 36426576
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial.
    Kim JH; Kim JY; Yoon MS; Kim YS; Lee JH; Kim HJ; Kim H; Kim YJ; Yoo CW; Nam BH; Kim TH; Kim SK; Kim SH; Kang S; Seo SS; Lim MC; Park SY
    Radiother Oncol; 2016 Sep; 120(3):383-389. PubMed ID: 27102843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
    Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escalated radiation and prophylactic extended field nodal irradiation are beneficial for FIGO IIIB cervical cancer patients' prognosis.
    Meng Q; Wang W; Liu X; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2018 Nov; 13(1):223. PubMed ID: 30453993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping patterns of para-aortic lymph node recurrence in cervical cancer: a retrospective cohort analysis.
    Bae BK; Park SH; Jeong SY; Chong GO; Kim MY; Kim JC
    Radiat Oncol; 2021 Jul; 16(1):128. PubMed ID: 34246296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified delineation method of para-aortic nodal clinical target volume in patients with locally advanced cervical cancer.
    Wang D; Wang W; Liu X; Ren K; Liang Y; Zhu Q; Zhang F; Hu K
    Cancer Med; 2022 Jan; 11(1):28-39. PubMed ID: 34783168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer.
    Oh J; Seol KH; Lee HJ; Choi YS; Park JY; Bae JY
    Radiat Oncol J; 2017 Dec; 35(4):349-358. PubMed ID: 29262671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.
    Liu X; Wang W; Meng Q; Zhang F; Hu K
    Jpn J Clin Oncol; 2019 Mar; 49(3):263-269. PubMed ID: 30668725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Extended-Field Irradiation Versus Pelvic Irradiation in Patients With Cervical Cancer With 2018 FIGO Stage IIIC1 Disease.
    Wang W; Meng Q; Zhou Y; Hu K; Zhang F; Qiu J; Hou X; Lian X; Yan J; Liu Z; Sun S; Ma J; Liu X
    Pract Radiat Oncol; 2023; 13(5):e409-e415. PubMed ID: 37075837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective observational study evaluating acute and delayed treatment related toxicities of prophylactic extended field volumetric modulated arc therapy with concurrent cisplatin in cervical cancer patients with pelvic lymph node metastasis.
    Ballari N; Rai B; Bahl A; Mittal BR; Ghoshal S
    Tech Innov Patient Support Radiat Oncol; 2021 Mar; 17():48-56. PubMed ID: 33748442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study.
    Yoon M; Lee HK; Park EY; Kim JH; Lee JH; Kim YS; Kim HJ; Kim H; Yoo CW; Lee S; Hong EK; Kim TH; Kim TS; Seo SS; Kang S; Chang SJ; Shin HJ; Uong TNT; Lee S; Kim JY
    Int J Cancer; 2022 Dec; 151(12):2182-2194. PubMed ID: 35751421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.